Topo
O site do Hospital Beatriz Ângelo usa cookies para assegurar uma experiência de utilização adequada e para conhecer o fluxo de visitas e suas características.
Ao navegar neste site está a consentir a utilização de cookies. Para mais informações consulte a Política de Cookies.
Serviço Nacional de Saúde
República Portuguesa

Hospital Beatriz Ângelo

Navegação Principal do site

Ensaios clínicos em recrutamento



Ensaios clínicos na área do carcinoma mama
  • OLYMPIA: A randomised, double-blind, parallel group, placebo-controlled multi-centre Phase III study to assess the efficacy and safety of olaparib versus placebo as adjuvant treatment in patients with germline BRCA1/2 mutations and high risk HER2 negative primary breast cancer who have completed definitive local treatment and neoadjuvant or adjuvant chemotherapy. Mais informações em: https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003839-30/PT
Ensaios clínicos na área da colite ulcerosa
Ensaios clínicos na área da diabetes
  • FIDELIO: A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease. Mais informações em: https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000990-11/PT
  • FIGARO: A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease in addition to standard of care. Mais informações em: https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000950-39/PT
Ensaios clínicos na área da doença de Alzheimer
Ensaios clínicos na área das infeções respiratórias
  • ASN100-201: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of a Single Dose of ASN100 for the Prevention of Staphylococcus aureus Pneumonia in Heavily Colonized, Mechanically Ventilated Subjects. Mais informações em: https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002146-23/PT

  • PROMIS I: A double-blind, placebo controlled, multicentre, clinical trial to investigate the efficacy and safety of 12 months of therapy with inhaled Promixin® (colistimethate sodium) in the treatment of subjects with non-cystic fibrosis bronchiectasis chronically infected with Pseudomonas aeruginosa (P. aeruginosa). Mais informações em: https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002743-33/PT
Ensaios clínicos na área do AVC
  • RESPECT ESUS: Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the Efficacy and safety of the oral Thrombin inhibitor dabigatran etexilate (110 mg or 150 mg, oral b.i.d.) versus acetylsalicylic acid (100 mg oral q.d.) in patients with Embolic Stroke of Undetermined Source. Mais informações em: https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003444-24/PT

Ensaios clínicos na área do HIV-2
Ensaios clínicos na área da doença renal crónica              


voltar
 
 
Luz Saúde, S.A., Sociedade Aberta © 2018